1. Structure‐based discovery of (S)‐2‐amino‐6‐(4‐fluorobenzyl)‐5, 6, 11, 11a‐tetrahydro‐1H‐imidazo[1′, 5′:1, 6]pyrido[3, 4‐b]indole‐1, 3(2H)‐dione as low nanomolar, orally bioavailable autotaxin inhibitor. (3rd January 2022) Authors: Roy, Ashis; Sarkar, Tonmoy; Datta, Sebak; Maiti, Arup; Chakrabarti, Monali; Mondal, Trisha; Mondal, Chaitali; Banerjee, Apurba; Roy, Subhasis; Mukherjee, Soumen; Muley, Pragati; Chakraborty, Sabyasachi; Banerjee, Manish; Kundu, Mrinalkanti; Roy, Kuldeep K. Journal: Chemical biology & drug design Issue: Volume 99:Number 3(2022) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗